BRK/B

Berkshire Hathaway
D

BRK/B Arincen57/100Beta

558.77
USD
1.21
(0.22%)
Market Open
Last updated: · Delayed 15 min
Fair valueNot reliable
Q3 FY2026 · Earnings report
EPS estimate 5.88Revenue estimate 100.96B
OverviewFinancialsSignalsForecastEarningsCompany

Berkshire Hathaway executives and insider trading

Gregory Edward Abel bought 21 shares for 0 USD and sold 0 for 0 USD on the open market over the last twelve months.

Over the last twelve months Berkshire Hathaway's insiders sold 39,700 shares for 19.97M USD in 1 sales on the open market, and bought 1,047 shares in 25 purchases.

Insiders over the last twelve months

Insider sales
1
Shares sold
39,700
Value sold
19.97M USD
Insider purchases
25

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
0
0
1 month
0
250.07K USD
3 months
19.97M USD
500.62K USD
6 months
19.97M USD
500.62K USD
1 year
19.97M USD
500.62K USD
2 years
28.42M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
Gregory Edward Abel CEOCEO, President & Director64——21——
Ajit Jain Vice Chairman of Insurance Operations & Director7439,70019.97M USD—28 Sept 2026—
Michael J. O'Sullivan Senior VP & General Counsel60——1,024——
Charles C. Chang Senior VP & CFO57——2——

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
28 Sept 2026Ajit JainSale39,700503.0919.97M USD67,608Form 4
12 Aug 2026Michael J. O'SullivanPurchase43513.6122.09K USD1,151Form 4
12 Aug 2026Michael J. O'SullivanPurchase400512.52205.01K USD1,108Form 4
12 Aug 2026Michael J. O'SullivanPurchase45510.6422.98K USD708Form 4
12 Aug 2026Charles C. ChangPurchase1——8Form 4
12 Aug 2026Charles C. ChangPurchase1——7Form 4
6 May 2026Michael J. O'SullivanPurchase53470.2224.92K USD663Form 4
6 May 2026Michael J. O'SullivanPurchase483467.13225.62K USD610Form 4
4 Mar 2026Gregory Edward AbelPurchase1——249Form 4
4 Mar 2026Gregory Edward AbelPurchase1——248Form 4
4 Mar 2026Gregory Edward AbelPurchase1——247Form 4
4 Mar 2026Gregory Edward AbelPurchase2——246Form 4
4 Mar 2026Gregory Edward AbelPurchase1——244Form 4
4 Mar 2026Gregory Edward AbelPurchase1——243Form 4
4 Mar 2026Gregory Edward AbelPurchase1——242Form 4

Common questions about Berkshire Hathaway's executives and insiders

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.